Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-076005
Filing Date
2022-03-15
Accepted
2022-03-15 16:02:26
Documents
5
Effectiveness Date
2022-03-15

Document Format Files

Seq Description Document Type Size
1 S-8 d334743ds8.htm S-8 42432
2 EX-5.1 d334743dex51.htm EX-5.1 5958
3 EX-23.1 d334743dex231.htm EX-23.1 1595
4 EX-FILING FEES d334743dexfilingfees.htm EX-FILING FEES 14854
5 GRAPHIC g334743dsp001.jpg GRAPHIC 9782
  Complete submission text file 0001193125-22-076005.txt   74053
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263562 | Film No.: 22741029
SIC: 2834 Pharmaceutical Preparations